NCT05020028 - Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Knee Arthritis

Interventions

DRUG

Cannabidiol (CBD)

Patients will be dispensed enough 25mg cannabidiol (CBD) Orally Disintegrating Tablets (ODT) to take a standard dose of 50mg three times daily for 84 days.

DRUG

Placebo

25mg Placebo ODT looks like the cannabidiol (CBD) Orally Disintegrating Tablets (ODT), but contains no active ingredients.

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York